health nexus<\/a>; Russ Cobb, PurpleLab chief marketing officer; and Dr. Ben Freiberg, Principal Informatics Systems Lead with Genentech\u2019s gCS Computational Catalysts. Genentech is part of Roche. <\/p>\n\n\n\nRWD can include data from an electronic medical record, medical claims data, data from disease registries or from connected devices.<\/p>\n\n\n\n
“When we look at large data sets, we need to think about what questions do we need the data to answer? If you’ve got clarity around that, then that can help filter out the noise,” Emrick said. “So with any patient journey, such as non-small cell lung cancer, when did the patient first start to have symptoms? What was the diagnosis? What type of medication did they get? Is it a targeted therapy versus a non-targeted therapy? Were there biomarker tests that were run? If not, why did they have access to that kind of treatment?”<\/p>\n\n\n\n
Freiberg observed that the more people can understand patient data beyond electronic medical records, the easier it will be to detect disease patterns and develop novel insights based on that information. <\/p>\n\n\n\n
The webinar also highlighted:<\/p>\n\n\n\n